Joint pain can be the result of a number of conditions, such as an injury or arthritis. Many patients with joint pain are likely to use medication or surgery. However, there is a groundbreaking treatment available that is natural, non-surgical, and requires very little downtime.
Bone marrow stem cell therapy with PRP injections, fat stem cell therapy with PRP injections, and amniotic/placenta stem cell therapy with PRP injections are three safe and minimally invasive procedures that use the healing abilities of your own cells to treat conditions like degenerated tendons, cartilage and ligament injuries, and advanced arthritis.
Bone marrow, fat, and amniotic/placenta cells with PRP therapy use a combination of regenerative cells and Platelet-Rich Plasma (PRP). Mega growth factors are present in amniotic and placenta tissue. Fat, and bone marrow have the unique capability of becoming other cells. Platelet-Rich Plasma is a serum created from blood that consists of platelets and proteins. Platelet-Rich Plasma is taken from the blood, not the fat, bone marrow, or amniotic/placenta tissues.
In order to prepare PRP, the doctor will draw a small blood sample from the patient and spin it at high speed in a centrifuge for about 40 minutes to separate the platelets and growth factors from other blood cells. The regenerative cells are then injected into the injured or arthritic joint along with PRP. The PRP causes mild inflammation, which then triggers the healing response. Guided by the platelets in PRP, regenerative cells then rebuild damaged tissue and develop new collagen. It is important to note that the regenerative cells need guiding signals from the platelets in order to do their jobs.
Bone marrow contains regenerative cells called mesenchymal regenerative cells (MSRs) or mesenchymal stem cells (MSCs). MSCs have the capability to turn into bone, cartilage, or muscle tissue, and can be taken from the crest of the patient’s hip bone. Bone marrow stem cell injections are accompanied by PRP injections at the injury site. Healing begins immediately, and generally takes about three months to complete.
The only real difference between fat cell therapy with PRP treatment and its bone marrow counterpart is that in fat cell therapy, the MSCs are usually taken from the patient’s hip or outer thigh fat tissue. The advantage to using MSCs from fat versus MSCs from bone marrow is that the process of collecting fat cells is less invasive than collecting bone marrow and more stem cells can be harvested in older patients. Bone marrow stem cells decreased in older patients.
While bone marrow and fat stem cell therapies are autologous (derived from the patient’s body), amniotic and placenta tissue are provided by a consenting donor and processed in an FDA-regulated lab to make sure they are disease-free and safe for use.
Amniotic and placenta are different from embryonic stem cells, but still have the capability to home many different kinds of cells to repair the injured site. As with bone marrow/fat cell therapy with PRP injections, amniotic and placenta tissue are injected into the treatment site along with PRP taken from the patient’s blood.
Regenerative cell therapy may be capable of repairing tissues that were previously thought to be irreparable, particularly cartilage, bone, and muscle. This is why Dr. Truong believes regenerative cell therapy to be the best treatment for arthritic joint pain from cartilage loss, and will help you decide which regenerative cell with PRP treatment is best for you.
Regenerative cell therapy is much less painful and invasive than surgery. Bone marrow and fat cell therapy with PRP also carries fewer risks than surgery because the MSCs and PRP are taken from the patient’s body, lowering the risk of rejection or allergic reaction. Amniotic/placenta therapy with PRP will also not result in rejection or allergic reaction.
Amniotic/placenta and bone marrow/fat cells have anti-inflammatory properties, which reduce pain, and promote hyaluronic acid, which is a key component of joint fluid that promotes cartilage growth.
If you are sick of joint treatments that don’t work or are seeking an alternative to surgery, or don’t want to take opioids pain medication, regenerative cells and PRP therapy may be right for you!
Bone marrow is flexible tissue in the interior of bones that produces red blood cells and immune cells. Bone marrow contains cells called mesenchymal stem cells (MSCs) and Hematopoietic stem cells, which have the potential to turn into many different kinds of cells, like bone, muscles, ligaments, cartilage.
Human adipose tissue (fat) is mostly made up of adipocytes, which store energy for the body. Like bone marrow, fat also contains mesenchymal stem cells (MSCs), which have the potential to turn into many different kinds of cells, like bones, muscles, ligaments, soft tissues, cartilage. Fat stem cells does not decrease with age, but bone marrow does.
The placenta nourishes the fetus in the womb and the amniotic fluid protects it. The placenta, amniotic fluid, and amniotic sac membranes contain high concentrations of multipotent stem cells, which have the potential to turn into many different kinds of cells.
Platelet-Rich Plasma (PRP) is a serum consisting of platelets and proteins. PRP is prepared from the patient’s own blood. To make PRP, a small blood sample is spun at high speed in a centrifuge to separate the platelets and growth factors from other cells.
Fat contains many types of cells, including stem cells. Fatty tissue taken from a patient’s hip or outer thigh is spun in a centrifuge to separate the stem cells, which will then be injected into a patient as part of fat cell therapy with PRP treatment.
The doctor will take a bone marrow sample from a patient’s body, usually from the crest of the hip. The bone marrow is then spun in a centrifuge to separate the stem cells, which will then be injected into a patient as part of bone marrow stem cell therapy with PRP.
FDA-approved amniotic and placenta tissue have a high concentration of growth factors, so much so that they can be injected into a patient without the stem cells needing to be extracted.